Condition: Acute Myeloid Leukemia · Sponsor: University of Colorado, Denver
Investigation of Relapsed or refractory AML with a monocytic phenotype after failure of hypomethylating agent+venetoclax
This description comes directly from the study's public registry record.
Derek Schatz · 720-848-0628 · derek.schatz@cuanschutz.edu
Always discuss trial participation with your own doctor first.
| Universtiy of Colorado Hospital | Aurora, Colorado, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06232655